Hong Kong-based surgical robotics company Cornerstone Robotics is making waves in the medical technology sector with plans to raise $70 million in 2025. The firm aims to bolster the development and global expansion of its cutting-edge robotic systems designed for minimally invasive surgeries.
Cornerstone's robotic systems have already been utilized in approximately 250 procedures, showcasing their potential to transform surgical practices. The company claims its technology rivals the market-leading da Vinci surgical systems while offering a more cost-effective solution, a factor that could disrupt the industry.
The funds raised will support product development, regulatory approvals, and international expansion, positioning Cornerstone as a formidable player in the global surgical robotics market. This follows their recent success in securing over $70 million in Series C funding earlier in 2025, led by investors like EQT and Hong Kong's Innovation and Technology Venture Fund.
With a mission to enhance accessibility to robotic surgery worldwide, Cornerstone is focused on driving innovation and improving patient outcomes. Their systems aim to reduce surgical risks and recovery times, offering a significant advancement in healthcare technology.
The company's ambition to compete with established players like da Vinci underscores Hong Kong's growing reputation as a hub for technological innovation. Industry experts are keenly observing how Cornerstone's strategic moves will impact the competitive landscape of surgical robotics.
As Cornerstone Robotics prepares for this significant funding round, the medical community and investors alike are eager to see how their advancements will shape the future of surgery. This initiative could mark a pivotal moment in making high-tech surgical solutions more accessible globally.
Andrew Lee
